Form 8.5 (EPT/RI)

On 13 July 2026, Shore Capital Stockbrokers Ltd disclosed client-serving dealings in Alternative Income REIT plc, buying 25,091 ordinary shares at 67.5p–68.15p and selling 30,937 ordinary shares at 68p–70p. No related indemnity or voting/derivatives arrangements were disclosed. This is a routine Rule 8.5 dealing disclosure and is unlikely to materially move the market.

Analysis

This filing is mostly microstructure noise, not a fundamental signal. In takeover situations, dealer flow like this can briefly nudge the arb spread, but it does not change the economics of the deal unless it is accompanied by a financing, regulatory, or vote-related event. The only immediate beneficiary is the liquidity provider capturing spread; existing holders and merger-arb funds should treat it as inventory management unless the stock starts trading away from the implied consideration.

The second-order issue is crowdedness: if the name is already owned by event-driven funds, repeated dealer selling can widen the discount to value even without any change in deal probability. That matters over days, not months, because arb books will only lean in if the gap compensates for break risk and timing risk. If the spread refuses to tighten after this type of flow, that is usually a sign the market is demanding a higher probability-adjusted return, not that the offer has deteriorated.

Contrarian read: consensus often over-interprets any Rule 8 disclosure as informed selling or buying, but the better inference is that a connected intermediary is facilitating client flow. The tradeable setup is not to chase the print, but to watch whether the security continues to trade near the deal floor; if it does, the market is saying the transaction remains intact. If the spread widens materially without a corresponding headline, that is the first real alert.

For now, this is a watch item, not a catalyst by itself. The falsifier is a measurable move in the implied spread, a formal regulatory setback, or a change in offer terms; absent that, the filing has little standalone value.

Key Decisions for Investors

• No new position on CGAC solely from this disclosure; treat it as non-informative flow unless the implied deal spread widens meaningfully over the next 1-3 sessions.
• If already long the arb, keep size modest and hedge market beta; use a widened spread versus deal value as the only entry point, not the disclosure itself.
• Set an alert for any 50-100 bps deterioration in the implied offer spread or any new Rule 8 filing with directional concentration; that would be a better signal of positioning stress.
• Avoid shorting into the disclosure unless the stock trades through a clear technical support level or the deal spread signals rising break risk; the downside from this filing alone is limited.